Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alder biopharmaceuticals
2
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
fda
2
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
2
×
texas top stories
wisconsin blog main
wisconsin top stories
advaxis
aimmune therapeutics
alexander hardy
amgen
andrew oxtoby
babies
breakup
bridge bio pharma
calcitonin gene-related peptide
ceo
chronic migraine
clinical hold
What
amgen
approval
big
bio
bosley's
bosley’s
bridge
bucks
candidates
cas
ceo
class
crime
crispr
departure
developed
drug
editas
exit
fda
gets
guiding
head
katrine
medicine
medicines
migraine
moves
new
nod
pain
personnel
preventive
roundup
starts
surprising
week
won
Language
Current search:
fda
×
" texas blog main "
×
" alder biopharmaceuticals "
×
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines